Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Tatva Chintan Pharma Chem Financial Results

Tatva Chintan Pharma Chem reported audited FY26 results and recommended a Rs. 2 per share dividend. Consolidated annual profit reached ₹42.05 Crore on ₹509.41 Crore revenue.

Key figures
Value₹4.68 Cr
Source

NSE filing, NSE: TATVA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Tatva Chintan Pharma Chem Ltd: key numbers

Share price
₹1,627.80
Market cap
₹3,808 Cr
Revenue (annual)
₹505.9 Cr
Net profit (annual)
₹42.05 Cr
P/E (TTM)
60.5×Sector 34.1×
Promoter holding
72.02%+0.00% QoQ
FII holding
4.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Tatva Chintan Pharma Chem Ltd

All →

Other financial results announcements

All →